Skip to Content

Chemical Biology and Pharmacology

National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD and surrounding area

Position Description:

We are soliciting applications for funded postdoctoral positions in biochemistry and chemical-biology in NIH/NIDDK/Laboratory of Bioorganic Chemistry/Chemical Biology in Signaling Section. Research will center on the synthesis of new chemical and immunological tools to study cell surface proteins, such as disease-relevant G protein coupled receptors.
See the following link as a primer on the types of tools to be developed in the laboratory: https://www.nature.com/articles/s41467-020-15884-8. See information about our research lab here: https://www.niddk.nih.gov/research-funding/at-niddk/labs-branches/laboratory-bioorganic-chemistry/chemical-biology-signaling-section/research

Qualifications:

A PhD in biochemistry, chemistry, or pharmacology (or related fields) is required. US citizenship is not a requirement. Applicants should be detail-oriented and highly organized with the ability to plan and have ownership of tasks to completion.
Additional attributes of interest (but which are not required) include knowledge of peptide or organic chemistry, protein expression and purification, and experience in cell-based assay development.

To Apply:

Please provide by email a CV and a summary of your PhD work (≤ 1 page). Provide a short description (1-3 sentences) of how your skills are suited to the areas of focus in the Cheloha lab.

Please see the following link for information on postdoctoral positions at NIH: https://www.training.nih.gov/programs/postdoc_irp.
Candidates from underrepresented groups are especially encouraged to apply.
Apply to: Ross Cheloha, Ph.D. National Institutes of Health, National Institute of Diabetes, Digestive and Kidney Disease; ross.cheloha@nih.gov

The NIH is dedicated to building a diverse community in its training and employment programs and encourages the application and nomination of qualified women, minorities, and individuals with disabilities.